The latest from DTC Perspectives
Doctor Endorsement Has Little Effect on Consumer Perception of Drug
Results from the Latest Survey on DTC
Thursday, 12 June 2008, 11:54 AM
Doctors’ endorsement of drugs in pharmaceutical ads has little impact on consumer perception of those drugs, according to the 11th annual national survey Consumer Reaction to DTC Advertising of Prescription Medicines. Seventy-five percent of consumers say a doctor’s appearance in an ad does not make an advertised medicine seem more effective, and 72% say it doesn’t make it seem safer. The survey results were released June 10 at a presentation to more than 200 pharmaceutical executives and industry leaders at the W Hotel in New York City.
Conducted by Prevention, Men's Healthand Women's Health magazines, with technical assistance from the Food and Drug Administration's Division of Drug Marketing, Advertising and Communication (DDMAC), this survey is one of the primary consumer studies informing the FDA's stance on DTC issues.
Mirroring overall trends in information seeking, the study found a significant increase in consumers using the Web for medical queries:
- More than half (53%) of all consumers go online to look for prescription drug information, vs. 41% in 2007, and 10% have clicked on a DTC banner ad, compared to 5% in 2006.
- Many have visited the Web site of a pharmaceutical company (50%) or advertised brand of medicine (40%).
"Consumers are firmly rooted in the era of online health management as more and more patients embrace tools and trackers such as Google, Yahoo and Revolution Health," said Cary Silvers, Director of Consumer Insights at Rodale, who spearheaded this year's survey. "Along with the doctor and pharmacist, the online component has become the third leg of the stool as consumers learn about drugs. The more consumers know, the more likely they are to take action."
"The need for treatment trumps everything, including any industry skepticism. DTC advertising is solution-based and if you have a condition, the information you receive from DTC ads will strongly resonate," said Bob Ziltz, VP/Publisher of Prevention. "Consumers are hungrier than ever for information, with all indicators trending higher in this year's study."
Other key findings from the 11th annual survey on Consumer Reaction to DTC Advertising of Prescription Medicine:
- Doctors' offices are valuable distributors of health information: 63% of consumers notice informational materials (posters, brochures, videos) featured there.
- The majority of consumers say that magazine DTC ads are "somewhat/very useful" in conveying a drug's benefits (75%) and risks (76%). Consumers feel similarly about TV DTC ads in conveying a drug's benefits (69%) and risks (78%). Fifty-six percent say that ads are "done responsibly."
- 58% of consumers are currently taking a prescription drug, compared to 47% ten years ago. Of those taking prescription medicines, 55% saw an advertisement for the medicine they were taking.
- Over a 5-year average, among every one who saw a DTC ad, 73% of the consumers talked to their doctor about a medicine while 25% asked the doctor to prescribe it. Of those who just talked about the drug, 25% received the prescription for the advertised medicine. Of those who specifically asked, 77% received the prescription.
- More than half of consumers (56%) say they do not follow news stories about pharmaceutical companies. In the same vein, negative attitudes towards pharmaceutical companies make no difference in consumer actions towards DTC ads. Whether they are favorable or not, the same amount of consumers talked with a doctor about a specific medicine they saw advertised.
Related articles
AMA Advocates Pre-Approval
At a Congressional hearing last month, American Medical Association president-elect Nancy Nielsen, MD, said the association supports giving FDA the resources and
DTC Perspectives, Inc. Announces the new DTC Hall of Fame Awards
DTC Perspectives, Inc. is proud to introduce the first DTC Hall of Fame Awards. This new award will honor and recognize individuals who have made significant
DTC INSIGHTS Alert: "Reported" Ad Spending Shows No Growth in Q1
The “reported” spending for DTC advertising was off slightly in the first quarter of 2008 (declining less than $1 million on a base of roughly $1.3 billion), according
blogspectives week of June 2, 2008
Welcome to our first issue of Blogspectives. Bi-weekly I will comment on health blogs that discuss pharmaceutical marketing, public policy, and consumer trends and
New Ad Campaign for Chantix Addresses Safety Concerns
Pfizer launched a new print advertising campaign May 29 for smoking-cessation treatment Chantix in five major newspapers that is intended to counter media reports
DTC and You
DTC in the Era of Consumer Choice
Register Now for this year's Fall Conference, focusing
on how DTC marketing must change in the face
of ever-increasing consumer pressures.
FREE Subscription to our Magazine
Start a free subscription now to the industry's leading
publication focused soley on DTC marketing,
DTC Perspectives Magazine is published quarterly.
Subscribe to DTC Insights
The DTC Marketer's Executive Brief - DTC INSIGHTS
takes all the information and data pertinent to DTC
and analyzes it for a busy pharma marketer.
Subscribe to Bob Ehrlich’s newsletter
A weekly blog column from DTCPI CEO Bob Ehrlich
that reflects his observations on key trends affecting
our industry.
| ABOUT SSL CERTIFICATES |

